InfuSystem Holdings, Inc. (NYSE:INFU) Receives Consensus Recommendation of “Buy” from Brokerages

Shares of InfuSystem Holdings, Inc. (NYSE:INFU) have been given an average rating of “Buy” by the five brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $14.50.

Several brokerages have recently commented on INFU. Lake Street Capital assumed coverage on InfuSystem in a report on Monday, September 22nd. They set a “buy” rating and a $15.00 target price for the company. Roth Capital reiterated a “buy” rating and issued a $14.00 target price (up from $13.00) on shares of InfuSystem in a report on Tuesday, November 4th. Finally, Zacks Research lowered shares of InfuSystem from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th.

InfuSystem Price Performance

Shares of NYSE:INFU opened at $8.60 on Friday. The company has a market capitalization of $174.89 million, a PE ratio of 143.36 and a beta of 1.68. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The stock has a fifty day moving average of $9.20 and a 200-day moving average of $8.90. InfuSystem has a one year low of $4.61 and a one year high of $11.04.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of INFU. Voya Investment Management LLC purchased a new stake in InfuSystem in the 1st quarter worth approximately $182,000. Integrated Quantitative Investments LLC purchased a new stake in shares of InfuSystem during the second quarter worth $243,000. Truffle Hound Capital LLC acquired a new stake in InfuSystem during the second quarter valued at $1,123,000. Connor Clark & Lunn Investment Management Ltd. increased its position in InfuSystem by 38.9% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 69,772 shares of the company’s stock worth $435,000 after purchasing an additional 19,554 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of InfuSystem during the 2nd quarter worth about $294,000. Hedge funds and other institutional investors own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.